In an article, published in an article,authors is Bertram, Lisa S., once mentioned the application of 102029-44-7, Name is (R)-4-Benzyl-2-oxazolidinone,molecular formula is C10H11NO2, is a conventional compound. this article was the specific content is as follows. 102029-44-7
SAR, pharmacokinetics, safety, and efficacy of glucokinase activating 2-(4-sulfonylphenyl)-N-thiazol-2-ylacetamides: Discovery of PSN-GK1
Allosteric activators of the glucose-sensing enzyme glucokinase (GK) are currently attracting much interest as potential antidiabetic therapies because they can achieve powerful blood glucose lowering through actions in multiple organs. Here, the optimization of a weakly active high-throughput screening hit to (2R)-2-(4-cyclopropanesulfonylphenyl)-N-(5-fluorothiazol-2-yl)-3- (tetrahydropyran-4-yl)propionamide (PSN-GK1), a potent GK activator with an improved pharmacokinetic and safety profile, is described. Following oral administration, this compound elicited robust glucose lowering in rats.
If you are interested in 102029-44-7, you can contact me at any time and look forward to more communication. 102029-44-7
Reference£º
Oxazolidine – Wikipedia,
Oxazolidine | C3H1732NO – PubChem